IGFBP2 and lung carcinoma: A multivariate analysis showed that lung cancer patients with higher IGFBP2 had a poor survival outcome (HR = 8.22; 95%CI 1.78–37.92, P = 0.007) after adjustment for histopathology, surgery, pathology, age, smoking history and stage (Fig. 7B).